Figure 2 | Scientific Reports

Figure 2

From: Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen gene

Figure 2

Characteristics of Docetaxel-resistant cell line, 22Rv1DR. (A) 22Rv1DR cells were treated with docetaxel at indicated concentrations. Seven days after treatment, cell viability was determined by WST-1 assay. Data shown are mean with SD (n = 5 in each group). (B) Cell lysates were harvested from LNCaP, PC-3, 22Rv1, 22Rv1DR cells and subjected to Western blot analysis for PSA and β-actin. The blots were cropped and full length blots are presented in Supplementary Information.

Back to article page